Certified Global Research Member
Key Questions Answered
- Global Market Outlook
- In-depth analysis of global and regional trends
- Analyze and identify the major players in the market, their market share, key developments, etc.
- To understand the capability of the major players based on products offered, financials, and strategies.
- Identify disrupting products, companies, and trends.
- To identify opportunities in the market.
- Analyze the key challenges in the market.
- Analyze the regional penetration of players, products, and services in the market.
- Comparison of major players’ financial performance.
- Evaluate strategies adopted by major players.
- Recommendations
Why Choose Market Research Future?
- Vigorous research methodologies for specific market.
- Knowledge partners across the globe
- Large network of partner consultants.
- Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- Trusted by fortune 500 companies/startups/ universities/organizations
- Large database of 5000+ markets reports.
- Effective and prompt pre- and post-sales support.
The market for duodenal cancer is significantly influenced by the incidence rates and epidemiological factors. Regions with higher prevalence rates and specific demographic characteristics contribute to the demand for diagnostic tools, treatments, and therapeutic interventions.
Market dynamics depends on the knowledge of risk factors and causative agents of duodenal cancer. Duodenal cancer is influenced by factors such as chronic inflammation, familial adenomatous polyposis, and other genetic predispositions which help define the market for prevention and targeted therapies.
The technology of diagnostics advanced affects the market by providing the possibilities of early detecting of duodenal cancer. Improved imaging methods, identification of biomarkers, and development of non-invasive diagnostic techniques help in proper disease management that determines market preferences.
The market is defined by the duodenal cancer treatments in place. Influence of innovations of surgical techniques, chemotherapy regimens, and targeted therapies on patient’s outcomes is the competitive landscape between pharmaceutical companies and healthcare providers.
Public health campaigns and screening activities are one of the forces in the market. The early detection through screening programs is capable of improvement the forecasts, which influences the demand for duodenal cancer related services and like, healthcare services and products as well.
The development of genetic testing and personalized medicine is among the factors which drive the market of the duodenal cancer. Knowing the genetic pattern of the patients with duodenal cancer leads to individualized therapeutic modalities which affect treatment choices and market trends.
Age structure and aging population as a demographic factor contribute to the incidence of duodenal cancer. The age of the world population is currently increasing leading to the possibility of age-related cancers that will affect the need for duodenal cancer diagnostics and treatments.
Committed partnerships between all healthcare players, describes pharmaceutical firms, research institutes and healthcare providers, are necessary for a market to be developed. Duodenum cancer treatments and diagnostics are assisted by partnerships and joint projects.
Duodenal cancer related products regulatory frameworks and approvals dictate the market entry and competitiveness, respectively. Rigorous regulatory processes determine the safety and effectiveness of treatments, defining the market as a whole.
The situation of health infrastructure and the availability of treatment influences the market dynamics. Satisfactory facilities, competent healthcare professionals, and the variety of treatment possibilities determine the general demand for healthcare services of duodenal cancer.
Duodenal cancer awareness and education projects affect market dynamics. Patients who are aware of everything are more likely to seek medical help, participate in screening programs and follow the recommended treatment plans that influence market trends.
Economic factors, including income levels and healthcare affordability, play a role in shaping the duodenal cancer market. Access to treatment and affordability of healthcare services impact the overall demand for diagnostics and therapies.
Duodenal Cancer Market Highlights:
Duodenal Cancer Market Scenario
The duodenal cancer market is projected to reach USD 3.85 Billion by 2030 at CAGR 12.54% during the forecast period 2022-2030 Duodenal cancer, also known as the small bowel cancer, are caused in the duodenum area of the small intestine.
Numerous factors such as the growing prevalence of rare cancers, rising prevalence of chronic diseases, increasing, technological advancements and growing geriatric population are expected to drive the growth of the market. For instance, in January 2018, GE Healthcare announced that it has entered into a long-term, strategic partnership with Roche Diagnostics to co-develop and market digital clinical decision support solutions. With this, the companies will initially focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.
Moreover, favorable healthcare expenditures boost the growth of the market. However, stringent government regulation for product approval and the high cost of the treatments may hamper the market growth during the assessment period.
Segmentation
The duodenal cancer market has been segmented into type, diagnosis, and treatment.
The market, on the basis of type, has been segmented into adenocarcinoma, sarcoma, neuroendocrine (carcinoid) tumors, and lymphoma.
The market, by diagnosis, has been segmented into endoscopy or colonoscopy, capsule endoscopy, barium X-ray, CT scan, MRI scan, and other tests.
The market, by treatment, has been segmented into surgery, radiotherapy, and chemotherapy.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The duodenal cancer market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European duodenal cancer market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.Â
The duodenal cancer market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The duodenal cancer market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key players
AbbVie, Inc., Pfizer Inc., Eli Lilly & Company, Bristol-Myers Squibb Company, F. Hoffman-La Roche Ltd., Becton, Dickinson & Company, Novartis AG, Ipsen Biopharmaceuticals Inc., Thermo Fisher Scientific, Abbott, G E Healthcare, Agilent Technologies Inc., AstraZeneca, Boehringer Ingelheim International GmbH, and Bayer AG are some of the key players in the duodenal cancer market.
Regional Market Summary
Duodenal Cancer Market Share (%), by Region, 2017
Source: World Health Organization (WHO), Centers for Disease Control and Prevention (CDC)
Geographically, the Americas is anticipated to dominate the duodenal cancer market owing to a well-developed healthcare sector, rising prevalence of rare and chronic disease and growing healthcare expenditure. According to an article published by, American Society of Clinical Oncology (ASCO) in January 2018, 67% of people diagnosed with duodenal cancer survive it for five years. Europe is expected to hold the second largest position in the duodenal cancer market. The market growth in this region is attributed to the growing prevalence of chronic diseases, availability of funds for research, and increasing healthcare expenditure. According to Cancer Research UK, 41,804 new cases of bowel cancer were reported in 2015 in the UK.
Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge patient population, continuously developing economies, rising prevalence of diseases and increasing government funding for the healthcare sector. According to a study published by the European Society for Medical Oncology in January 2016, there were 4.3 million new cancer cases in China in 2015.
On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.
Duodenal Cancer Market, by Type
- Adenocarcinoma
- Sarcoma
- Neuroendocrine (carcinoid) tumors
- Lymphoma
Duodenal Cancer Market, by Diagnosis
- Endoscopy or Colonoscopy
- Capsule Endoscopy
- Barium X-Ray
- CT Scan
- MRI Scan
- Other Tests
Duodenal Cancer Market, by Treatment
- Surgery
- Radiotherapy
- Chemotherapy
Duodenal Cancer Market, by Region
- Americas
- North America
- US
- Canada
- South America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Leading companies partner with us for data-driven Insights
Kindly complete the form below to receive a free sample of this Report
Tailored for You
- Dedicated Research on any specifics segment or region.
- Focused Research on specific players in the market.
- Custom Report based only on your requirements.
- Flexibility to add or subtract any chapter in the study.
- Historic data from 2014 and forecasts outlook till 2040.
- Flexibility of providing data/insights in formats (PDF, PPT, Excel).
- Provide cross segmentation in applicable scenario/markets.
